Blended care intervention for parents with PTSD
KopOpOuders-PTSD: Randomized Controlled Trial of A Preventive Blended Care Parenting Intervention for Parents With PTSD
This study tests a new support program for parents with PTSD to see if it can help them be better parents and prevent mental health problems in their kids.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 142 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Arkin Industry-sponsored |
| Locations | 1 site (Amstelveen) |
| Trial ID | NCT05237999 on ClinicalTrials.gov |
What this trial studies
KopOpOuders-PTSD is a preventive blended care intervention designed for parents diagnosed with post-traumatic stress disorder (PTSD). This study aims to evaluate its effectiveness in enhancing parenting skills and preventing mental health issues in their children. The intervention was developed in collaboration with parents experiencing PTSD and focuses on improving parenting behavior, perceived competence, and social support. The study employs a single-blind randomized controlled trial design with multiple measurement points to assess the outcomes.
Who should consider this trial
Good fit: Ideal candidates for this study are parents aged 4-17 with a current DSM-5 diagnosis of PTSD who are receiving treatment.
Not a fit: Patients with urgent care needs, severe psychological issues, or those not in contact with children may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly improve parenting abilities and reduce mental health problems in children of parents with PTSD.
How similar studies have performed: Other studies have shown success in similar preventive interventions for parents with mental illness, suggesting a promising approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion criteria: In order to be eligible to participate in this study, a subject must meet all of the following criteria: * Has current DSM-5 diagnosis of PTSD; * Is receiving PTSD treatment of at least three sessions at one of the following Arkin departments: Sinai Centrum, Jellinek, Punt P, NPI, or Arkin BasisGGZ; * Has parenting responsibilities for at least one child aged 4-17 (biological or legal relationship not required). Exclusion Criteria: A potential subject who meets any of the following criteria will be excluded from participation in this study: * Has urgent care needs or (imminent) crisis (e.g. current psychosis, substance detoxification, active suicidality); * Is not in contact with children (e.g. due to out of home placement); * Is receiving another form of parenting intervention during the participation period; * Severe psychological problems or intellectual disability (IQ \< 50) are present in children (diagnosis of oppositional-defiant disorder, conduct disorder, psychotic spectrum disorder or personality disorder); * Inability to participate in the intervention and/or assessments (e.g., because of intellectual disability (IQ \< 75), illiteracy, or insufficient mastery of the Dutch language).
Where this trial is running
Amstelveen
- Sinai Centrum — Amstelveen, Netherlands (Recruiting)
Study contacts
- Principal investigator: Kathleen Thomaes — Sinai Centrum
- Study coordinator: Laurien Meijer
- Email: laurien.meijer@sinaicentrum.nl
- Phone: +31205457327
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.